Endorcine System IV Flashcards
1
Q
The pancreas
Length
Location
Parts
A
15-25cm long
Location: retro-peritoneum
Parts: head, neck, body and tail
2
Q
Pancreas main functions
A
Primarily involved with the digestive system (exocrine)
Role in regulating blood glucose concentrations (endocrine)
3
Q
Histology of pancreatic tissue
25%, 60%, 10%
A
- islets observed as relatively pale staining population
- extremely rich capillary supply
- 25% glucagon producing cells (alpha)
- 60% insulin producing cells (beta)
- 10% somatostatin producing cells (delta)
- Ghrelin producing cells
4
Q
Islets of langerhans
A
- different cell types within an islet not randomly distributed
- betal cells occupy the central portion of the islet and are surrounded by a rind of alpha and delta cells
- adult humans have 2000-3000 beta cells with approx 1 mill islets scattered through pancreas
5
Q
Insulin
A
- a peptide hormone highly conserved sequence among most vertebrates
- insulin mRNA is translated as a single chain precursor called pre-proinsulin and remove of its signal peptide generates pro-insulin
- cleavage of pro-insulin by enzymes -> generates mature form of insulin plus C peptide
6
Q
Insulin function
A
- acts on tissues (liver, skeletal muscles, adipose) to increase uptake of glucose and amino acids
- increases glycogen production
- stimulates lipid synthesis from free fatty acids
- increased activity of glucose transporters = move glucose into cells
- control of intermediary metabolism
7
Q
Regulation of insulin release
A
- major stimulus: increased blood glucose levels
- amino acids and keto acids also stimulate insulin
- some neural stimuli
- inhibited by stress-induced responses
8
Q
Blood glucose concentration
A
- the normal fasting blood glucose concentration in humans and most mammals is 80-90mg per 100 mL
- glucose is liberated from dietary carbohydrate within the SI, then absorbed into the blood
- almost immediately after the infusion begins, plasma insulin levels increase
9
Q
Glucagon
A
- a 29 AA polypeptide hormone that is a potent hypoerglycaemic agent
- synthesised as pro-glucagon and proteolytic ally processed to yield glucagon within alpha cells of the pancreatic islets
- promotoes breakdown of triglycerides from adipose tissue and release of fatty acids into the blood
10
Q
Glucagon processes
A
- promotes breakdown of glycogen in the liver
- promoted synthesis of glucose from simpler molecules - process called gluconeogenesis
11
Q
Regulation of glucagon secretion
A
- produced by alpha cells in the pancreas
- increased blood glucose levels inhibit glucagon release
- amino acids stimulate glucagon release
- stress: epinephrine acts on beta-adrenrgic receptor on alpha cells, increasing glucagon release
- insulin inhibits glucagon secretion
- remember glucocorticoids
- stimulate gluconeogenesis and lipolysis
12
Q
Somatostatin
A
- named for its effect of inhibiting secretion of growth hormone
- GH secretion is controlled by the interaction of SS and GHRH
- appears to act primarily in a paracrine manner to inhibit the secretion of both insulin and glucagon
- injection of SS into the brain leads to arousal, decreased sleep and impairment of some motor responses
- it is also sometimes used to treat gigantism and acromegaly
13
Q
Blood glucose regulation
A
- control involves liver (makes and exports glucose) and pancreas (released insulin and glucagon)
- parasympatheis nervous system: stimulated insulin secretion
- sympathetic nervous system: stimulates glucagon secretion
14
Q
Type 1 diabetes
A
- aka insulin dependent diabetes mellitus
- diabetes currently affects aroung 200 million people -> 10% of these cases type 1 diabetes
- require insulin delivery
- results in hyperglycaemia
- glucose cannot enter the adipose cells
- juvenile onset = genetic susceptibility
- immune system destroys beta cells in pancreas
15
Q
Type 1 diabetes symptoms and consequences
A
- polyuria and polydipsia
- polyphagia
- diabetic retinopathy
- nephropathy
- diabetric neuropathy, damage to nerves, especially in peripheral tissues
- increased risk of myocardial infarction and stroke
- circulatory problems which can lead to gangrene
- foot problems